Short answer
Indivior Pharmaceuticals, Inc. (INDV) filed an 8-K current report with the SEC on March 13, 2026 reporting Item 8.01 (Other Events). Indivior pricing 0.625% convertible senior notes due 2031: unusually low coupon signals strong investor demand or significant equity conversion premium.
Indivior Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Indivior pricing 0.625% convertible senior notes due 2031: unusually low coupon signals strong investor demand or significant equity conversion premium
- Convertible structure means potential shareholder dilution if notes convert to common stock at maturity or trigger conditions
- 5-year tenor (2026–2031) suggests medium-term capital raise likely for operations, pipeline investment, or debt refinancing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Indivior Pharmaceuticals, Inc. 8-K filings
Get the next INDV 8-K as it lands
Follow INDV for push alerts, or ask the research agent what this filing means.